Action TMBRQ TREX WIND-DOWN, INC.
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Trex Wind-down, Inc.

Actions

TMBRQ

US8870802084

Marché Fermé - OTC Markets
Autres places de cotation
 17:28:09 09/05/2024 		Varia. 5j. Varia. 1 janv.
0,0001 USD -50,00% Graphique intraday de Trex Wind-down, Inc. 0,00% -91,67%
04/04 Première demande d'extension de la période d'exclusivité approuvée pour Timber Pharmaceuticals, Inc. CI
20/03 Approbation provisoire de la deuxième déclaration d'information révisée et du plan de Timber Pharmaceuticals, Inc. CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Second Revised Combined Joint Liquidation Plan and Disclosure Statement Approved for Trex Wind-down, Inc.
First Motion for Exclusivity Period Extension Approved For Timber Pharmaceuticals, Inc.
Second Revised Disclosure Statement and Plan Approved on Interim Basis for Timber Pharmaceuticals, Inc.
First Motion for Exclusivity Period Extension Filed by Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. Presents Preliminary Results from the ASCEND Trial in A Late-Breaking Session At the 2024 American Academy of Dermatology Annual Meeting
Combined Joint Liquidation Plan & Disclosure Statement Filed by Timber Pharmaceuticals, Inc.
LEO Pharma finalizes acquisition of key assets from Timber Pharmaceuticals
Motion for Asset Sale Approved for Timber Pharmaceuticals, Inc.
LEO Pharma A/S completed the acquisition of Substantially All the assets from Timber Pharmaceuticals, Inc. (OTCPK:TMBR.Q).
Notice of Selection of Winning Bidder & Asset Purchase Agreement Filed for Timber Pharmaceuticals, Inc.
Notice for Auction Cancellation Filed by Timber Pharmaceuticals, Inc.
Bidding Procedure Approved for Timber Pharmaceuticals, Inc.
Final DIP Financing Approved for Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals to Be Delisted From NYSE American
Timber Pharmaceuticals Announces Commencement of NYSE American Delisting Proceedings: Common Stock Expected to Begin Trading on the OTC Market
Timber Pharmaceuticals Receives Court Approval of Motions to Support Business Operations
Timber Pharmaceuticals Receives Court Approval of All “First Day” Motions to Support Business Operations & Discloses Communication From NYSE American
Timber Pharmaceuticals, Inc.(NYSEAM:TMBR) dropped from S&P TMI Index
Interim DIP Financing Approved for Timber Pharmaceuticals, Inc.
Motion for Joint Administration Approved for Timber Pharmaceuticals, Inc.
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action TMBRQ
  4. Actualités Trex Wind-down, Inc.
  5. Autres langues